These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18630674)

  • 1. [Construction and expression characteristics in vitro of human papillomavirus type 16 E7 suicidal DNA vaccine].
    Wang HR; Wang BN; Li WY; Zuo FQ; Li H; Jiang ZH; Shi QF; Li MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):165-8. PubMed ID: 18630674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of human papillomavirus type 16 genotype and construction of cloning vector pTZ57R encoding HPV16 E7 gene.
    Meshkat Z; Soleimanjahi H; Mahmoudi M; Mirshahabi H; Hassan ZM; Ghaffari SR; Sabokbar T
    Saudi Med J; 2007 Oct; 28(10):1511-5. PubMed ID: 17914510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
    Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
    Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
    Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
    Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
    Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
    Brulet JM; Maudoux F; Thomas S; Thielemans K; Burny A; Leo O; Bex F; Hallez S
    Eur J Immunol; 2007 Feb; 37(2):376-84. PubMed ID: 17274002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prokaryotic expression and identification of human papillomavirus type 16 E7 protein encoding gene].
    Shi QF; Wang BN; Li H; Wei XL; Zhang WD; Cao K; Jiang ZH; Li MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):187-90. PubMed ID: 16608071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death.
    Kim TW; Hung CF; Juang J; He L; Hardwick JM; Wu TC
    Gene Ther; 2004 Feb; 11(3):336-42. PubMed ID: 14737094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
    Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new type HPV16 E7 variant isolated from cervical cancer highest incidence area in Hubei Province of China.
    Li H; Zhao M; Qiu X; Ding X; Tan Y; Wu X
    Eksp Onkol; 2004 Mar; 26(1):48-54. PubMed ID: 15112580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prokaryotic expression and identification of human papillomavirus type 16 E5 protein].
    Shi QF; Wei XL; Li H; Wang BN; Zhang WD; Jiang ZH; Cao K; Li MY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):31-5. PubMed ID: 16495171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
    Dell K; Klein C; Gissmann L
    Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.
    Wang-Johanning F; Gillespie GY; Grim J; Rancourt C; Alvarez RD; Siegal GP; Curiel DT
    Cancer Res; 1998 May; 58(9):1893-900. PubMed ID: 9581830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of human papillomavirus 16 E5 on malignancy of human cervical cancer cells and the mechanism there of].
    Liao SJ; Deng DR; Xia X
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3080-4. PubMed ID: 19192411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
    Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.
    Smahel M; Poláková I; Pokorná D; Ludvíková V; Dusková M; Vlasák J
    Int J Oncol; 2008 Jul; 33(1):93-101. PubMed ID: 18575754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.